Iambic Therapeutics (IAM) is trading down at $15.57 (-4.72%), as of the latest quote. It operates in the sector.
Iambic Therapeutics prices IPO at $16 per share on Nasdaq
Iambic Therapeutics prices IPO at $16 per share on Nasdaq
Iambic Therapeutics prices IPO at $16 per share
Iambic Therapeutics prices IPO at $16 per share
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on